Kazia Therapeutics Ltd (ASX:KZA) insider Steven Coffey bought 60,000 shares of the company’s stock in a transaction dated Wednesday, July 3rd. The shares were acquired at an average price of A$0.33 ($0.23) per share, for a total transaction of A$19,860.00 ($14,085.11).
ASX:KZA opened at A$0.41 ($0.29) on Friday. Kazia Therapeutics Ltd has a 52 week low of A$0.32 ($0.23) and a 52 week high of A$0.60 ($0.43). The firm has a market cap of $19.61 million and a PE ratio of -1.64. The company’s 50-day simple moving average is A$0.39.
About Kazia Therapeutics
Featured Article: Asset Allocation
Receive News & Ratings for Kazia Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kazia Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.